|Articles|July 15, 2015

Sharon L. Bober, PhD, Discusses Sexual Health Changes in Relation to Treatment

Sharon L. Bober, PhD, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses how changes in sexual health differ with various treatments.

Newsletter

Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.

Subscribe Now!

Related Content

Graphic featuring photos of Julie Zgola and Emily Coiro donating stem cells

Stem Cell Transplant Nurse and NP Give Bone Marrow Donation

ByBridget Hoyt

November 27th 2025

Chemo-Induced Myelosuppression Presentation and Management in ES-SCLC

ByKennon McCollum, DNP

November 22nd 2025

What Biomarker Testing Is Required Up Front in Ovarian Cancer?

ByCourtney R. Arn, APRN-CNP

November 18th 2025

Linking Mechanism of Action to Safety Profiles in mCRC Treatment

ByGabriel Schwartz, MSN, NP

November 15th 2025

Addressing Common Talquetamab Misunderstandings

BySamantha Shenoy, MSN, NP,Alan Plisskin,Mary Kay Yamamoto

November 14th 2025

Sharon L. Bober, PhD, Discusses Sexual Health Changes in Relation to Treatment

Newsletter

Related Content

Stem Cell Transplant Nurse and NP Give Bone Marrow Donation

Chemo-Induced Myelosuppression Presentation and Management in ES-SCLC

What Biomarker Testing Is Required Up Front in Ovarian Cancer?

Linking Mechanism of Action to Safety Profiles in mCRC Treatment

Addressing Common Talquetamab Misunderstandings

Trending on Oncology Nursing News

Case Study: Breast Oncology APPs Across the Cancer Continuum

Age, Parental Status Factors in Fertility Decisions in Premenopausal Breast Cancer

ADC Receives Orphan Drug Designation in Small Cell Lung Cancer